T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Targeted delivery of immunomodulatory compounds to defined subsets of endogenous immune cells may improve the efficacy of combination immunotherapies. Here, the authors use PD-1-targeting nanoparticles containing a TGFβ inhibitor or a TLR7/8 agonist to deliver these payloads to T cells or via T cell...
Guardado en:
Autores principales: | Daniela Schmid, Chun Gwon Park, Christina A. Hartl, Nikita Subedi, Adam N. Cartwright, Regina Bou Puerto, Yiran Zheng, James Maiarana, Gordon J. Freeman, Kai W. Wucherpfennig, Darrell J. Irvine, Michael S. Goldberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08f1cc43b00d4985af2f7a6446427a7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Rui Xing, et al.
Publicado: (2021) -
Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
por: Xiaobo Zheng, et al.
Publicado: (2021) -
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Baharak Bahmani, et al.
Publicado: (2021) -
Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
por: Xianda Zhao, et al.
Publicado: (2021) -
Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data
por: YANG Xi, et al.
Publicado: (2021)